Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic intravenous cefoperazone duration after Kasai procedure in biliary atresia
ChiCTR-IPR-16008609Phase 4Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefoperazone in biliary atresia (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Percentage of cholangitis at 6 months after Kasai procedure. Started Jul 2016; status: completed.
02
Drugs
cefoperazone
03
Conditions
biliary atresia
Beyond the preview
Go deeper on ChiCTR-IPR-16008609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008609.